What is the clinical significance and management approach based on the Malanpathy score in acute pancreatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Significance and Management Approach Based on Scoring Systems in Acute Pancreatitis

There is no "gold standard" prognostic score for predicting severe acute pancreatitis, but the Bedside Index of Severity of Acute Pancreatitis (BISAP) score is recommended as one of the most accurate and applicable scoring systems in everyday clinical practice due to its simplicity and ability to predict severity, death, and organ failure. 1

Understanding Severity Assessment in Acute Pancreatitis

Severity stratification in acute pancreatitis is crucial for:

  • Early identification of high-risk patients
  • Appropriate resource allocation
  • Timely intervention to reduce morbidity and mortality
  • Guiding management decisions

Key Scoring Systems and Their Clinical Utility

  1. BISAP Score

    • Most practical for everyday clinical use
    • Simple to calculate
    • Effectively predicts severity, mortality, and organ failure
    • Can be calculated within 24 hours of admission
  2. Glasgow Score

    • Validated in UK populations
    • Three or more positive criteria (based on initial admission score and subsequent tests over 48 hours) indicates severe disease
    • 70-80% accuracy in prognostication 1
    • Should be assessed in all patients within 48 hours of admission
  3. APACHE II Score

    • Equally accurate as Glasgow score
    • Score ≥9 indicates severe attack
    • Score ≥6 includes nearly all complications (sensitivity 95%)
    • Allows for ongoing assessment through daily scoring
    • Pattern of change indicates recovery, disease progression, or onset of sepsis 1
    • More complex to calculate but useful for monitoring severe cases
  4. C-reactive Protein (CRP)

    • Independent prognostic value
    • Peak level >210 mg/l in first four days (or >120 mg/l at end of first week)
    • Approximately 80% accuracy
    • Can improve prognostication when combined with Glasgow criteria 1
  5. Other Scoring Systems

    • Ranson criteria: PPV ranges from 28.6-49% (sensitivity 75-87%, specificity 68-77.5%)
    • PANC 3 score: High specificity (100%) and accuracy (91.4%) but lower sensitivity (50%) 2
    • CT Severity Index (CTSI): Useful for radiological assessment of severity

Management Algorithm Based on Severity Scores

Step 1: Initial Assessment (0-24 hours)

  • Calculate BISAP score and APACHE II score on admission
  • Measure CRP levels
  • Begin Glasgow score assessment

Step 2: Comprehensive Severity Stratification (24-48 hours)

  • Complete Glasgow score assessment
  • Monitor CRP levels (peak at day 3-4)
  • Continue daily APACHE II scoring in suspected severe cases
  • Recommendation: All patients should be assessed by the Glasgow score and CRP within 48 hours 1

Step 3: Radiological Assessment (3-10 days)

  • For patients with predicted severe attack: Perform contrast-enhanced (dynamic) CT scan
  • Timing: Between 3-10 days after admission
  • Purpose: Assess degree of pancreatic necrosis and surrounding fluid collections
  • Recommendation: A dynamic CT scan should be performed in all severe cases between 3-10 days after admission 1

Step 4: Management Based on Severity

  • Mild Acute Pancreatitis:

    • Standard supportive care
    • Early oral feeding when tolerated
    • Treat underlying cause (e.g., gallstone removal)
  • Severe Acute Pancreatitis:

    • Consider ICU admission (75% of patients requiring intensive care are transferred within first 72 hours) 1
    • Aggressive fluid resuscitation
    • Nutritional support (preferably enteral)
    • Monitor for and treat complications
    • Consider interventions for specific etiologies (e.g., ERCP for biliary pancreatitis)

Important Considerations and Pitfalls

  • Timing Limitations: Most severity scores take more than 24 hours to stratify patients, potentially delaying critical interventions 1
  • Evolving Disease: Pancreatic necrosis may not be fully evident within first 48 hours, limiting early CT scanning for severity prediction 3
  • Outcome Focus: Most prediction scores focus on death as an outcome, but with declining mortality rates, other outcomes may be more relevant 1
  • Clinical Assessment Alone: Unreliable and may misclassify around 50% of patients 1
  • Complementary Approach: No single score is perfect - using multiple assessment tools improves accuracy

Aetiological Assessment

Determining the cause of acute pancreatitis is essential as it affects management decisions:

  • Clinical history (alcohol intake, viral exposure, comorbidities, medications)
  • Biochemical assessment (early increase in aminotransferases or bilirubin suggests gallstone etiology)
  • Radiological assessment (ultrasound for gallstones, repeated if initially negative)
  • For idiopathic pancreatitis: At least two ultrasound examinations should be performed to rule out biliary etiology 1

By systematically applying these scoring systems and following the management algorithm, clinicians can effectively stratify patients with acute pancreatitis and provide appropriate care based on predicted severity.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

THE PANC 3 SCORE PREDICTING SEVERITY OF ACUTE PANCREATITIS.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery, 2016

Research

Predicting Severity of Acute Pancreatitis.

Medicina (Kaunas, Lithuania), 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.